» Articles » PMID: 32431280

The Impact of Control Interventions on Malaria Burden in Young Children in a Historically High-Transmission District of Uganda: A Pooled Analysis of Cohort Studies from 2007 to 2018

Abstract

There is limited evidence on whether malaria elimination is feasible in high-transmission areas of Africa. Between 2007 and 2018, we measured the impact of malaria control interventions in young children enrolled in three clinical trials and two observational studies in Tororo, Uganda, a historically high-transmission area. Data were pooled from children aged 0.5-2 years. Interventions included individually assigned chemoprevention and repeated rounds of indoor residual spraying (IRS) of insecticide. All children received long-lasting insecticidal nets (LLINs) and treatment for symptomatic malaria with artemisinin-based combination therapy. Malaria incidence was measured using passive surveillance and parasite prevalence by microscopy and molecular methods at regular intervals. Poisson's generalized linear mixed-effects models were used to estimate the impact of various control interventions. In total, 939 children were followed over 1,221.7 person years. In the absence of chemoprevention and IRS (reference group), malaria incidence was 4.94 episodes per person year and parasite prevalence 47.3%. Compared with the reference group, implementation of IRS was associated with a 97.6% decrease (95% CI: 93.3-99.1%, = 0.001) in the incidence of malaria and a 96.0% decrease (95% CI: 91.3-98.2%, < 0.001) in parasite prevalence (both measured after the fifth and sixth rounds of IRS). The addition of chemoprevention with monthly dihydroartemisinin-piperaquine to IRS was associated with a 99.5% decrease (95% CI: 98.6-99.9%, < 0.001) in the incidence of malaria. In a historically high-malaria burden area of Uganda, a combination of LLINs, effective case management, IRS, and chemoprevention was associated with almost complete elimination of malaria in young children.

Citing Articles

Differences in phenotype between long-lived memory B cells against Plasmodium falciparum merozoite antigens and variant surface antigens.

Reyes R, Turner L, Ssewanyana I, Jagannathan P, Feeney M, Lavstsen T PLoS Pathog. 2024; 20(10):e1012661.

PMID: 39466842 PMC: 11542837. DOI: 10.1371/journal.ppat.1012661.


Differences in phenotype between long-lived memory B cells against merozoite antigens and variant surface antigens.

Reyes R, Turner L, Ssewanyana I, Jagannathan P, Feeney M, Lavstsen T bioRxiv. 2024; .

PMID: 38895251 PMC: 11185507. DOI: 10.1101/2024.06.01.596978.


Did the prolonged residual efficacy of clothianidin products lead to a greater reduction in vector populations and subsequent malaria transmission compared to the shorter residual efficacy of pirimiphos-methyl?.

Odjo E, Akpodji C, Djenontin A, Salako A, Padonou G, Adoha C Malar J. 2024; 23(1):119.

PMID: 38664703 PMC: 11047034. DOI: 10.1186/s12936-024-04949-4.


Atypical B cells consist of subsets with distinct functional profiles.

Reyes R, Batugedara G, Dutta P, Reers A, Garza R, Ssewanyana I iScience. 2023; 26(12):108496.

PMID: 38098745 PMC: 10720271. DOI: 10.1016/j.isci.2023.108496.


Plasmodium falciparum infection and disease in infancy associated with increased risk of malaria and anaemia in childhood.

Andronescu L, Buchwald A, Sharma A, Bauleni A, Mawindo P, Liang Y Malar J. 2023; 22(1):217.

PMID: 37496052 PMC: 10369742. DOI: 10.1186/s12936-023-04646-8.


References
1.
Morris U, Msellem M, Mkali H, Islam A, Aydin-Schmidt B, Jovel I . A cluster randomised controlled trial of two rounds of mass drug administration in Zanzibar, a malaria pre-elimination setting-high coverage and safety, but no significant impact on transmission. BMC Med. 2018; 16(1):215. PMC: 6287359. DOI: 10.1186/s12916-018-1202-8. View

2.
Hofmann N, Mwingira F, Shekalaghe S, Robinson L, Mueller I, Felger I . Ultra-sensitive detection of Plasmodium falciparum by amplification of multi-copy subtelomeric targets. PLoS Med. 2015; 12(3):e1001788. PMC: 4348198. DOI: 10.1371/journal.pmed.1001788. View

3.
Trape J, Sauvage C, Ndiaye O, Douillot L, Marra A, Diallo A . New malaria-control policies and child mortality in senegal: reaching millennium development goal 4. J Infect Dis. 2012; 205(4):672-9. PMC: 3764592. DOI: 10.1093/infdis/jir805. View

4.
Oxborough R . Trends in US President's Malaria Initiative-funded indoor residual spray coverage and insecticide choice in sub-Saharan Africa (2008-2015): urgent need for affordable, long-lasting insecticides. Malar J. 2016; 15:146. PMC: 4784374. DOI: 10.1186/s12936-016-1201-1. View

5.
Eisele T, Bennett A, Silumbe K, Finn T, Chalwe V, Kamuliwo M . Short-term Impact of Mass Drug Administration With Dihydroartemisinin Plus Piperaquine on Malaria in Southern Province Zambia: A Cluster-Randomized Controlled Trial. J Infect Dis. 2016; 214(12):1831-1839. PMC: 5142084. DOI: 10.1093/infdis/jiw416. View